FGF19 and hepatocellular carcinoma: Combined treatment of FGF401 and vinorelbine can synergistically inhibit the growth of HCC tumor models with high expression of FGF19 and promote cell apoptosis, thereby prolonging the overall survival of mice and improving the antitumor activity [342].